Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Large Growth in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 61,662 shares, an increase of 274.3% from the June 30th total of 16,476 shares. Based on an average daily trading volume, of 256,414 shares, the short-interest ratio is currently 0.2 days. Approximately 12.1% of the shares of the stock are short sold.

Analyst Ratings Changes

A number of analysts have issued reports on AMIX shares. Weiss Ratings downgraded Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a research note on Friday, July 10th. Zacks Research upgraded Autonomix Medical to a “hold” rating in a research report on Tuesday, June 2nd. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $42.00.

Autonomix Medical Stock Performance

Shares of NASDAQ:AMIX traded down $0.58 on Friday, reaching $2.92. The company’s stock had a trading volume of 7,992,176 shares, compared to its average volume of 230,123. The company has a 50-day simple moving average of $6.95 and a 200 day simple moving average of $8.02. Autonomix Medical has a 52-week low of $2.90 and a 52-week high of $32.55. The company has a market cap of $1.58 million, a P/E ratio of -0.04 and a beta of -1.32.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.